You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
The study will evaluate the efficacy of AZD5423 in patients with mild asthma challenged with an inhaled allergen
- Disease
- asthma
- Drug Name
- AZD5423
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Oct 25, 2010
- Study Name
- D2340C00005
- Study Id
- D2340C00005
- ClinicalTrials.gov ID
- NCT01225549
- Recruiting Status
- Not Yet Recruiting
- Protocol Status
- Not Available
- Report Status
- Not Available
